Building a tuberculosis-free world while responding to the COVID-19 pandemic
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-03
Type
Journal Article
Author
Michael J. A. Reid
Author
Sachin Silva
Author
Nimalan Arinaminpathy
Author
Eric Goosby
URL
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32138-3/abstract
Series
Comment
Volume
396
Issue
10259
Pages
1312-1313
Publication
The Lancet
ISSN
0140-6736, 1474-547X
Date
24/10/2020
Extra
Publisher: Elsevier
Journal Abbr
The Lancet
DOI
10.1016/S0140-6736(20)32138-3
Library Catalog
www.thelancet.com
Language
English
Abstract
In March, 2019, the Lancet Commission on Tuberculosis1 highlighted the opportunity
to build a tuberculosis-free world. After years of neglect of this disease, the UN
High-Level Meeting on Tuberculosis in September, 2018, made ending tuberculosis a
global priority; global leaders committed to important steps, including ambitious
country-specific tuberculosis case-finding and prevention targets, and a revitalised
research agenda.2 The Lancet Commission concluded that the prospect of a tuberculosis-free
world was a realistic objective that could be achieved with sufficient accountability
and resources, and detailed the catastrophic consequences of failing to build on that
momentum.